Lowest effective dose tailored to you Fewer side effects minimal nausea, fatigue Better protein intake & muscle preservation Dose adjusted based on labs & response Hormone & root-cause investigation Built-in exit strategy from medication Sustainable, long-term results Fixed escalation regardless of response More nausea, vomiting, fatigue Significant muscle loss reported No labs, no individual monitoring Hormones & root causes never addressed No plan to come off medication Weight regain when medication stops How the 12-Week Program Works From your first consultation to your final follow-up, every step is designed to produce lasting results
Aim for at least 150 minutes of moderate-intensity exercise, like brisk walking, each week
We have eagerly awaited seeing the actual results since the sponsor company (Novo Nordisk) issued a press release in August that proclaimed a 20% relative reduction of cardiovascular death, heart attack or stroke, the primary endpoint of the trial
Semaglutide, with its 7-day half-life and once-weekly dosing, represents the longest-acting formulation currently available [23]
